prostate cancer screening cut death rate study
researcher add widescale testing linked overdiagnosis overtreatment thursday march healthday news study sweden suggests screening prostate cancer substantially reduce risk death disease
hand good many men might receive result overtreatment adding element risk widescale screening researcher report march online issue bmj
light finding would say benefit screening sufficient support mass screening said study author gabriel sandblom associate professor karolinska institute stockholm
however added sandblom study initiated year ago psa prostate specific antigen testing available treatment localized prostate cancer effective today
would thus categorically advise psa testing based individual decision man feel concern prostate cancer
advice line recently updated guideline prostate cancer screening government
recommendation issued take dim view prostate cancer screening age healthy men flatly recommend entirely men
american cancer society also recently revisited issue prostate cancer screening
little year ago american cancer society revised guideline reinforced message men need informed known benefit also limit psa screening said durado brook director prostate colon cancer american cancer society
american cancer society encourage discourage prostate cancer screening
new study carry several significant weakness brook added
particular timing design study men really received one two psa test
best study one two psa test men late early said
study researcher looked men swedish city norrkoping age total men
men screened prostate cancer first digital rectal exam dre starting dre psa test every three year
men aged screened
remaining men undergo screening served comparison group
mortality rate men underwent screening significantly different control group although tumor screened group tended smaller localized
commenting study chad lagrange assistant professor urology university nebraska medical center omaha said belief finding actually add much uncertainty already complex problem
study subject guideline become vague recommendation said
really good rule anymore
bottom line simple psa screening either work
patient talk doctor lagrange said
psa testing reflex anymore
good news hidden number prostate cancer death continues decline whether better screening better treatment said
something right lagrange stated
information
